CD40LG and plasma cell myeloma: Gradually, several studies using different techniques, such as Sanger sequencing, polymerase chain reaction (PCR), and allele-specific PCR (ASqPCR), confirmed that MYD88L265P is highly frequent in WM (up to 95% of patients) and IgM-MGUS (at least 50%) (Table S1), whereas it is absent in patients with multiple myeloma (MM) (including the IgM isotype) and rarely found in other indolent lymphoid disorders [11,12,13,14,15,16].